Special Investigation in Patients With Ulcerative Colitis

Trial Profile

Special Investigation in Patients With Ulcerative Colitis

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions
  • Sponsors AbbVie
  • Most Recent Events

    • 24 Jul 2017 Planned End Date changed from 28 Jul 2017 to 31 Mar 2018.
    • 10 Jun 2017 Biomarkers information updated
    • 21 Apr 2017 Planned End Date changed from 1 Aug 2018 to 28 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top